Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

Gene editing

Home » Emerging technologies » Gene editing » Page 2

Algentech

Algentech Granted US Patent For A Key Genome Editing Technology

Horizon Discovery to Provide Access to Novel Base Editing Technology

Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics

Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applications

LogicBio Therapeutics Announces Collaboration with Takeda to Develop New Genome Editing Candidate LB-301 for the Treatment of Crigler-Najjar Syndrome

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

SNIPR BIOME Strengthens Lead in CRISPR-based Medicines to Treat Microbiomes

CRISPR Prime

With CRISPR Prime, gene therapies are one step closer to curing millions

Mammoth Biosciences Strengthens Executive Management With Biotech Veterans, Peter Nell and Ted Tisch

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery